Cargando…
A new high-content screening assay of the entire hepatitis B virus life cycle identifies novel antivirals
BACKGROUND & AIMS: Chronic hepatitis B is an incurable disease. Addressing the unmet medical need for therapies has been hampered by a lack of suitable cell culture models to investigate the HBV life cycle in a single experimental setup. We sought to develop a platform suitable to investigate al...
Autores principales: | Yang, Jaewon, König, Alexander, Park, Soonju, Jo, Eunji, Sung, Pil Soo, Yoon, Seung Kew, Zusinaite, Eva, Kainov, Denis, Shum, David, Windisch, Marc Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243515/ https://www.ncbi.nlm.nih.gov/pubmed/34222850 http://dx.doi.org/10.1016/j.jhepr.2021.100296 |
Ejemplares similares
-
Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine
por: Andersen, Petter I., et al.
Publicado: (2019) -
A Simple and Cost-Effective DNA Preparation Method Suitable for High-Throughput PCR Quantification of Hepatitis B Virus Genomes
por: Jo, Eunji, et al.
Publicado: (2020) -
Identification and Tracking of Antiviral Drug Combinations
por: Ianevski, Aleksandr, et al.
Publicado: (2020) -
Seven classes of antiviral agents
por: Ianevski, Aleksandr, et al.
Publicado: (2022) -
Broad-Spectrum Antivirals and Antiviral Combinations: An Editorial Update
por: Kainov, Denis, et al.
Publicado: (2022)